Literature DB >> 4999540

Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia.

H M Grey, E Rabellino, B Pirofsky.   

Abstract

The distribution of peripheral blood lymphocytes that contain surface Ig has been studied by means of immunofluorescence in humans. Normal individuals, individuals with sex-linked and acquired agammaglobulinemia, selective IgA deficiency, cellular immune deficiencies, and individuals with chronic lymphatic leukemia (CLL) were studied. Approximately 28% of the peripheral blood lymphocytes from normal individuals contained surface Ig. On an average 15% contained IgG, 6%, IgA, and 8%, IgM; and the kappa: lambda ratio was 2:1. Lymphocytes from patients with CLL appeared to be "monoclonal" in that the cells from a given individual had a single Ig associated with them (e.g., kappa IgM). In three-quarters of the cases the H chain class was IgM; in the remaining one-quarter no H chain could be detected on the cell surface. The L chain class was kappa in 12 cases and lambda in 8. Four patients with sex-linked agammaglobulinemia and one with "acquired" agammaglobulinemia had markedly decreased numbers of cells with surface Ig (0-4%). In contrast, the three patients with selective IgA deficiency and no detectable serum IgA contained normal numbers of cells (6-8%) with surface IgA. Five patients with cellular deficiency states, including two with Wiskott-Aldrich syndrome, contained a normal or low percentage of cells with surface Ig.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4999540      PMCID: PMC292179          DOI: 10.1172/JCI106735

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity.

Authors:  M D Cooper; H P Chae; J T Lowman; W Krivit; R A Good
Journal:  Am J Med       Date:  1968-04       Impact factor: 4.965

2.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

3.  The transformation of human lymphocytes by monkey antisera to human immunoglobulins.

Authors:  J J Oppenheim; G N Rogentine; W D Terry
Journal:  Immunology       Date:  1969-01       Impact factor: 7.397

4.  Ficoll flotation for the separation of blood leukocyte types.

Authors:  P B Noble; J H Cutts; K K Carroll
Journal:  Blood       Date:  1968-01       Impact factor: 22.113

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Selective enzyme purification by affinity chromatography.

Authors:  P Cuatrecasas; M Wilchek; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

7.  Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor.

Authors:  A S Levin; L E Spitler; D P Stites; H H Fudenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

8.  Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin.

Authors:  E R Unanue; H M Grey; E Rabellino; P Campbell; J Schmidtke
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

9.  STUDIES ON RABBIT LYMPHOCYTES IN VITRO. I. STIMULATION OF BLAST TRANSFORMATION WITH AN ANTIALLOTYPE SERUM.

Authors:  S SELL; P G GELL
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

10.  INDIVIDUAL ANTIGENIC SPECIFICITY OF MYELOMA PROTEINS. CHARACTERISTICS AND LOCALIZATION TO SUBUNITS.

Authors:  H M GREY; M MANNIK; H G KUNKEL
Journal:  J Exp Med       Date:  1965-04-01       Impact factor: 14.307

View more
  104 in total

1.  Increased proliferation of T lymphocytes in the blood of patients with Hodgkin's disease.

Authors:  C Huber; G Michlmayr; M Falkensamer; U Fink; G Zur Nedden; H Braunsteiner; H Huber
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

2.  [Separation and immunological characterization of lymphocytes isolated from human appendix (author's transl)].

Authors:  G Breucha; G Riethmüller; E P Rieber
Journal:  Klin Wochenschr       Date:  1975-12-15

3.  Free immunoglobulin light chain synthesis by lymphocytes from patients with hypogammaglobulinaemia.

Authors:  J Gordon; J L Smith
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

4.  Lymphocyte transformation in mycosis fungoides.

Authors:  A Langner; W Gliński; M Pawińska; S Obalek
Journal:  Arch Dermatol Forsch       Date:  1975

5.  [Lymphocyte in chronic lymphatic leukemia].

Authors:  G Brittinger; W Augener; K Bremer; G Cohnen; S Dabag; K Fischer; E König; P Meusers
Journal:  Blut       Date:  1975-05

6.  The lymphocyte plasma membrane: locus of control in the immune response.

Authors:  L M Jerry; A K Sullivan
Journal:  In Vitro       Date:  1976-03

7.  Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines.

Authors:  E M Shevach; R Herberman; M M Frank; I Green
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

8.  T lymphocytes bearing complement receptors in a patient with chronic lymphocytic leukaemia.

Authors:  H R Toben; R G Smith
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

9.  Surface receptors on human haematopoietic cell lines.

Authors:  C Huber; C Sundström; K Nilsson; H Wigzell
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

10.  Antigen heterogeneity of human B and T lymphocytes.

Authors:  E M Rabellino; H M Grey; S LaForge; B Pirofsky; N Kashiwagi; A Malley
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.